Clinical Trial Update: PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

View source ↗

Summary

An observational, recruiting study assessing the Merit HeRO Graft and Super HeRO Graft for hemodialysis access in patients with end-stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• HeRO Graft
• Super HeRO Graft

Snippet

Sponsor: Merit Medical Systems, Inc. | Conditions: End Stage Renal Disease, Hemodialysis Access Failure | Status: RECRUITING